Categories
Most Viewed Transcripts
- Netflix Inc (NFLX) Q3 2023 Earnings Call Transcript
- Tesla Inc (TSLA) Q3 2023 Earnings Call Transcript
- Accenture plc (ACN) Q3 2023 Earnings Call Transcript
- Steelcase Inc. (SCS) Q1 2024 Earnings Call Transcript
- Avid Bioservices Inc. (CDMO) Q4 2023 Earnings Call Transcript
- Patterson Companies, Inc. (PDCO) Q4 2023 Earnings Call Transcript
Latest News
Analysis
Key takeaways from Amazon’s Q1 2024 earnings report
Amazon.com Inc. (NASDAQ: AMZN) had an upbeat start to fiscal 2024, delivering strong growth across the business in the first three months
Key takeaways from Pfizer’s (PFE) Q1 2024 earnings report
Shares of Pfizer Inc. (NYSE: PFE) gained over 5% on Wednesday following the company’s announcement of its first quarter 2024 earnings results.
Walt Disney (DIS) to report Q2 earnings on May 7. Here’s what to expect
The Walt Disney Company (NYSE: DIS) is preparing to publish second-quarter earnings next week, amid expectations for a mixed outcome. The entertainment
Interviews
AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.
Most Read
Infographic: Key metrics from Estee Lauder’s (EL) Q3 2024 earnings results
The Estee Lauder Companies Inc. (NYSE: EL) reported its third quarter 2024 earnings results today. Net sales were $3.94 billion, up 5% from the prior-year quarter. Organic sales increased 6%.
May 1, 2024
YUM Earnings: Key quarterly highlights from Yum! Brands’ Q1 2024 financial results
Yum! Brands, Inc. (NYSE: YUM) reported first quarter 2024 earnings results today. Total revenues decreased 3% year-over-year to $1.59 billion. Same-store sales declined 3%. Net income increased 5% to $314
May 1, 2024
Pfizer (PFE) Q1 2024 Earnings: Key financials and quarterly highlights
Pfizer Inc. (NYSE: PFE) reported first quarter 2024 earnings results today. Revenues decreased 20% year-over-year to $14.8 billion. Reported net income declined 44% to $3.1 billion, or $0.55 per share,
May 1, 2024
Technology
Energy
Consumer
Industrials
Health Care
Research Summary
Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company that works with leading researchers
Trxade Health Inc. (NASDAQ: MEDS) Q4 2023 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) operates as an integrated drug procurement and delivery platform,